Finance

Lists
600216:SHA
Zhejiang Medicine Co Ltd
CN¥11.98
-1.72%
(-0.21) 1D
Oct 15, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600216...
Open
CN¥12.07
High
CN¥12.14
Low
CN¥11.89
Mkt. cap
11.72B
Avg. vol.
13.93M
Volume
12.17M
Dividend
2.34%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jul 9, 2026
P/E ratio
14.34
52-wk high
CN¥18.58
52-wk low
CN¥10.94
EPS
CN¥0.84
Shares outstanding
965.26M
No. of employees
5K
Open
CN¥12.07
High
CN¥12.14
Low
CN¥11.89
Mkt. cap
11.72B
Avg. vol.
13.93M
Volume
12.17M
Dividend
2.34%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jul 9, 2026
P/E ratio
14.34
52-wk high
CN¥18.58
52-wk low
CN¥10.94
EPS
CN¥0.84
Shares outstanding
965.26M
No. of employees
5K
News stories
From web sources and news partners
About Zhejiang Medicine Co Ltd
CEO-
Employees5.42K
FoundedMay 16, 1997
Headquarters-
SectorPharmaceutical industry
Websitezmc.top
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.37B
2.19B
2.19B
2.20B
Cost of goods sold
1.50B
1.80B
1.42B
1.36B
Cost of revenue
1.50B
1.80B
1.42B
1.36B
Research and development expenses
159.77M
106.60M
93.81M
152.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
349.18M
401.70M
336.15M
363.22M
Operating expense
494.12M
548.81M
437.74M
530.96M
Total operating expenses
1.99B
2.35B
1.86B
1.89B
Operating income
377.63M
-163.00M
330.27M
301.46M
Other non operating income
85.57M
-93.78M
-41.66M
40.12M
EBT including unusual items
287.43M
-94.58M
306.45M
313.26M
EBT excluding unusual items
365.43M
-181.96M
304.24M
287.43M
Income tax expense
45.26M
11.92M
48.09M
56.06M
Effective tax rate
15.75%
-12.60%
15.69%
17.89%
Other operating expenses
-8.55M
37.06M
4.17M
16.50M
Net income
259.84M
-59.77M
287.01M
319.00M
Net profit margin
10.95%
-2.73%
13.10%
14.53%
Earnings per share
-
-
-
-
Interest and investment income
11.28M
6.19M
20.45M
29.71M
Interest expense
-6.44M
-6.35M
-4.82M
-6.48M
Net interest expenses
4.84M
-157.28K
15.62M
23.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
541.53M
14.46M
507.74M
477.07M
Gain or loss from assets sale
178.71K
81.15K
-
-18.70K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps